Low-dose CT is currently used in Russia mainly as a way to detect lung cancer in its early stages and is more effective than a chest x-ray, noted Alex Gromov, the company's head of R&D, adding that the same may be true for COVID-19-related pneumonia.

The firm has used an artificial intelligence (AI) algorithm to detect lung lesions while also keeping the dose low for patients: 1.5 mSv versus the standard 7 mSv of CT.